Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.
Mol Carcinog
; 56(8): 1896-1908, 2017 08.
Article
in En
| MEDLINE
| ID: mdl-28277622
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Peritoneal Neoplasms
/
Mifepristone
/
Neoplasms, Glandular and Epithelial
/
Receptors, CXCR4
/
Chemokine CXCL12
/
Neoplasm Invasiveness
/
Antineoplastic Agents
Language:
En
Journal:
Mol Carcinog
Journal subject:
BIOLOGIA MOLECULAR
/
NEOPLASIAS
Year:
2017
Document type:
Article
Affiliation country:
China